BridgeBio Pharma (BBIO)
Develops and commercializes genetically targeted medicines through a decentralized portfolio model.
$77.93
After hours+8.69 (+12.55%)
At close$69.24(+4.00%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 36 days
EPS estimate
−$0.67
Revenue estimate
$269.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported−$1.31−$0.88−$0.95−$0.95−$1.00−$0.84−$0.78Pending
Estimate−$1.09−$1.00−$0.83−$0.88−$0.71−$0.68−$0.58−$0.67
Surprise−20.2%+12.0%−14.5%−8.0%−40.2%−23.8%−35.5%—
RevenueReportedEstimate
Feb '25Apr '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$5.9M$116.6M$110.6M$120.7M$154.2M$194.5M$243.7MPending
Estimate$4.0M$68.4M$108.1M$148.2M$146.8M$178.1M$220.9M$269.0M
Surprise+45.6%+70.5%+2.3%−18.5%+5.0%+9.2%+10.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | $2.37 | — | — |
| Sep 2029 | $2.19 | — | — |
| Jun 2029 | $2.03 | — | — |
| Mar 2029 | $1.87 | — | — |
| Dec 2028 | $1.15 | — | — |
| Sep 2028 | $0.98 | — | — |
| Jun 2028 | $0.82 | — | — |
| Mar 2028 | $0.54 | — | — |
| Dec 2027 | $0.42 | — | — |
| Sep 2027 | $0.04 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.24 | — | — |
| Dec 2026 | −$0.43 | — | — |
| Oct 2026 | −$0.67 | — | — |
| Aug 2026 | −$0.58 | −$0.78 | −35.5% |
| May 2026 | −$0.68 | −$0.84 | −23.8% |
| Feb 2026 | −$0.71 | −$1.00 | −40.2% |
| Oct 2025 | −$0.88 | −$0.95 | −8.0% |
| Aug 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Jun 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | $2.37 | — | — | $1.05B | — | — | — |
| Sep 2029 | $2.19 | — | — | $971.4M | — | — | — |
| Jun 2029 | $2.03 | — | — | $899.4M | — | — | — |
| Mar 2029 | $1.87 | — | — | $827.6M | — | — | — |
| Dec 2028 | $1.15 | — | — | $675.7M | — | — | — |
| Sep 2028 | $0.98 | — | — | $649.3M | — | — | — |
| Jun 2028 | $0.82 | — | — | $584.9M | — | — | — |
| Mar 2028 | $0.54 | — | — | $525.0M | — | — | — |
| Dec 2027 | $0.42 | — | — | $511.3M | — | — | — |
| Sep 2027 | $0.04 | — | — | $429.2M | — | — | — |
| Jun 2027 | −$0.18 | — | — | $376.9M | — | — | — |
| Mar 2027 | −$0.24 | — | — | $308.7M | — | — | — |
| Dec 2026 | −$0.43 | — | — | $314.8M | — | — | — |
| Oct 28, 2026 | −$0.67 | — | — | $269.0M | — | — | — |
| Aug 10, 2026 | −$0.58 | −$0.78 | −35.5% | $220.9M | $243.7M | +10.3% | −1.2% |
| May 7, 2026 | −$0.68 | −$0.84 | −23.8% | $178.1M | $194.5M | +9.2% | −0.1% |
| Feb 24, 2026 | −$0.71 | −$1.00 | −40.2% | $146.8M | $154.2M | +5.0% | −2.6% |
| Oct 29, 2025 | −$0.88 | −$0.95 | −8.0% | $148.2M | $120.7M | −18.5% | −4.9% |
| Aug 5, 2025 | |||||||
| Apr 29, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 14, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Jun 28, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |